SG11201606151SA - Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions - Google Patents

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

Info

Publication number: SG11201606151SA
Authority: SG; Singapore
Prior art keywords: compositions; solid pharmaceutical; pharmaceutical compositions; biopterin derivatives; biopterin
Prior art date: 2014-03-31

Application number

SG11201606151SA

Inventor

Peter Scheurer

Frank Tegtmeier

Reinhard Schinzel

Original Assignee

Vasopharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-03-31

Filing date

2015-03-30

Publication date

2016-08-30

2015-03-30 Application filed by Vasopharm Gmbh filed Critical Vasopharm Gmbh

2016-08-30 Publication of SG11201606151SA publication Critical patent/SG11201606151SA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Dispersion Chemistry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SG11201606151SA 2014-03-31 2015-03-30 Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions SG11201606151SA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP14162727.3A EP2926805B1 (en)	2014-03-31	2014-03-31	Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
PCT/EP2015/056824 WO2015150294A1 (en)	2014-03-31	2015-03-30	Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

Publications (1)

Publication Number	Publication Date
SG11201606151SA true SG11201606151SA (en)	2016-08-30

Family

ID=50389975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201606151SA SG11201606151SA (en)	2014-03-31	2015-03-30	Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

Country Status (29)

Country	Link
US (6)	US9895372B2 (en)
EP (2)	EP2926805B1 (en)
JP (3)	JP6552515B2 (en)
KR (1)	KR102374500B1 (en)
CN (2)	CN113521017A (en)
AU (2)	AU2015239736B2 (en)
CA (1)	CA2938267C (en)
CL (1)	CL2016002463A1 (en)
CY (1)	CY1117881T1 (en)
DK (1)	DK2926805T3 (en)
ES (1)	ES2586945T3 (en)
HK (1)	HK1213195A1 (en)
HR (1)	HRP20160802T1 (en)
HU (1)	HUE030221T2 (en)
IL (1)	IL248090B (en)
MX (1)	MX2016012784A (en)
MY (1)	MY180844A (en)
PE (1)	PE20161253A1 (en)
PH (1)	PH12016501519A1 (en)
PL (1)	PL2926805T3 (en)
PT (1)	PT2926805T (en)
RS (1)	RS54973B1 (en)
RU (1)	RU2694368C2 (en)
SA (1)	SA516371933B1 (en)
SG (1)	SG11201606151SA (en)
SI (1)	SI2926805T1 (en)
SM (1)	SMT201600246B (en)
WO (1)	WO2015150294A1 (en)
ZA (1)	ZA201605271B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112016018062B1 (en)	2014-02-07	2022-11-16	Exithera Pharmaceuticals Inc	THERAPEUTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION AND USES
PL2926805T3 (en)	2014-03-31	2016-12-30		Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
JP2016168783A (en) *	2015-03-13	2016-09-23	株式会社東芝	Recording device, recording method and recording medium
EP3675863A4 (en) *	2017-09-01	2021-01-27	PTC Therapeutics MP, Inc.	Pharmaceutical compositions comprising sepiapterin and uses thereof
JP6565103B2 (en) *	2017-09-06	2019-08-28	株式会社昭和冷凍プラント	Method for producing liquid product containing aroma component-containing aqueous solution
BR112022003719A2 (en) *	2019-09-25	2022-05-31	Ptc Therapeutics Mp Inc	Methods for the treatment of hyperphenylalaninemia
CA3235704A1 (en)	2021-12-03	2023-06-08	Verinos Operations Gmbh	Methods of treating patients suffering from brain injury and methods of increasing the value of the extended glasgow outcome scale of patients suffering from brain injury
US20230381184A1 (en) *	2022-05-06	2023-11-30	Verinos Operations Gmbh	Methods of treating patients suffering from a disease condition or disorder that is associated with an increased glutamate level

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5922713A (en) *	1997-06-26	1999-07-13	Werner; Ernst	Inhibition of nitric oxide synthase
EP0906913B1 (en)	1997-10-06	2001-05-23	Ernst Werner	Pteridinderivatives as NO synthase inhibitors
US6803046B2 (en) *	2002-08-16	2004-10-12	Bracco International B.V.	Sincalide formulations
WO2005037286A1 (en) *	2003-03-25	2005-04-28	Vasopharm Biotech Gmbh	Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
WO2005065018A2 (en) *	2003-11-17	2005-07-21	Merck Eprova Ag	Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride
EP1757293B1 (en) *	2004-05-11	2012-10-10	Daiichi Sankyo Company, Limited	Bh4-responsive hyperphenylalaninemia remedies
SE0401826D0 (en)	2004-07-09	2004-07-09	Trimble Ab	Method of preparing a winding for an n-phase motor
JP2008520574A (en) *	2004-11-17	2008-06-19	バイオマリンファーマシューティカルインコーポレイテッド	Tetrahydrobiopterin stable tablet formulation
EP1669355A1 (en) *	2004-12-02	2006-06-14	Vasopharm Biotech GmbH	Aminotetrahydropteridines and processes for manufacture thereof
MX2009010977A (en)	2007-04-11	2010-02-12	Biomarin Pharm Inc	Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring.
CN101658067B (en)	2007-04-24	2012-06-27	欧司朗股份有限公司	Circuit arrangement for igniting and operating a discharge lamp
WO2010017570A2 (en)	2008-08-12	2010-02-18	Orpha Swiss Gmbh	Pharmaceutical form comprising tetrahydrobiopterin
EP2680848A4 (en) *	2011-03-01	2014-11-05	Rubicon Res Private Ltd	Stable compositions of tetrahydrobiopterin
US9006289B2 (en) *	2011-08-30	2015-04-14	Fresenius Kabi Usa, Llc	Levothyroxine formulations
PL2926805T3 (en) *	2014-03-31	2016-12-30		Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

2014
- 2014-03-31 PL PL14162727.3T patent/PL2926805T3/en unknown
- 2014-03-31 RS RS20160595A patent/RS54973B1/en unknown
- 2014-03-31 SI SI201430042A patent/SI2926805T1/en unknown
- 2014-03-31 ES ES14162727.3T patent/ES2586945T3/en active Active
- 2014-03-31 DK DK14162727.3T patent/DK2926805T3/en active
- 2014-03-31 EP EP14162727.3A patent/EP2926805B1/en active Active
- 2014-03-31 PT PT141627273T patent/PT2926805T/en unknown
- 2014-03-31 HU HUE14162727A patent/HUE030221T2/en unknown
2015
- 2015-03-30 KR KR1020167025896A patent/KR102374500B1/en active IP Right Grant
- 2015-03-30 JP JP2016556270A patent/JP6552515B2/en active Active
- 2015-03-30 AU AU2015239736A patent/AU2015239736B2/en active Active
- 2015-03-30 CN CN202110640860.1A patent/CN113521017A/en active Pending
- 2015-03-30 CN CN201580017915.6A patent/CN106572976A/en active Pending
- 2015-03-30 US US14/913,665 patent/US9895372B2/en active Active
- 2015-03-30 MX MX2016012784A patent/MX2016012784A/en unknown
- 2015-03-30 WO PCT/EP2015/056824 patent/WO2015150294A1/en active Application Filing
- 2015-03-30 SG SG11201606151SA patent/SG11201606151SA/en unknown
- 2015-03-30 PE PE2016001818A patent/PE20161253A1/en unknown
- 2015-03-30 CA CA2938267A patent/CA2938267C/en active Active
- 2015-03-30 RU RU2016141449A patent/RU2694368C2/en active
- 2015-03-30 EP EP15715697.7A patent/EP3125864A1/en not_active Withdrawn
- 2015-03-30 MY MYPI2016702995A patent/MY180844A/en unknown
2016
- 2016-02-03 HK HK16101231.9A patent/HK1213195A1/en unknown
- 2016-07-06 HR HRP20160802TT patent/HRP20160802T1/en unknown
- 2016-07-26 SM SM201600246T patent/SMT201600246B/en unknown
- 2016-07-29 ZA ZA2016/05271A patent/ZA201605271B/en unknown
- 2016-08-01 PH PH12016501519A patent/PH12016501519A1/en unknown
- 2016-08-04 CY CY20161100768T patent/CY1117881T1/en unknown
- 2016-09-27 SA SA516371933A patent/SA516371933B1/en unknown
- 2016-09-27 IL IL24809016A patent/IL248090B/en active IP Right Grant
- 2016-09-29 CL CL2016002463A patent/CL2016002463A1/en unknown
2017
- 2017-05-02 US US15/584,890 patent/US10016431B2/en active Active
2018
- 2018-06-08 US US16/003,374 patent/US10493075B2/en active Active
2019
- 2019-07-02 JP JP2019123306A patent/JP6879582B2/en active Active
- 2019-10-21 US US16/659,401 patent/US10925877B2/en active Active
2020
- 2020-06-12 AU AU2020203880A patent/AU2020203880B2/en active Active
2021
- 2021-01-20 US US17/153,749 patent/US11717522B2/en active Active
- 2021-04-22 JP JP2021072278A patent/JP7178731B2/en active Active
2023
- 2023-07-20 US US18/224,515 patent/US20230355630A1/en active Pending

Also Published As

Publication number	Publication date
HRP20160802T1 (en)	2016-08-12
PT2926805T (en)	2016-07-15
US20200046710A1 (en)	2020-02-13
US10925877B2 (en)	2021-02-23
AU2015239736A1 (en)	2016-08-11
JP6552515B2 (en)	2019-07-31
RU2016141449A (en)	2018-05-07
CL2016002463A1 (en)	2017-01-27
US20230355630A1 (en)	2023-11-09
NZ722455A (en)	2022-03-25
HK1213195A1 (en)	2016-06-30
JP2017509623A (en)	2017-04-06
RU2694368C2 (en)	2019-07-12
CN106572976A (en)	2017-04-19
DK2926805T3 (en)	2016-07-25
RU2016141449A3 (en)	2018-12-14
US20210137927A1 (en)	2021-05-13
US10493075B2 (en)	2019-12-03
PE20161253A1 (en)	2016-11-13
WO2015150294A1 (en)	2015-10-08
SMT201600246B (en)	2016-08-31
KR102374500B1 (en)	2022-03-15
US20170296543A1 (en)	2017-10-19
JP2019194227A (en)	2019-11-07
BR112016020101A8 (en)	2021-06-29
PL2926805T3 (en)	2016-12-30
ES2586945T3 (en)	2016-10-19
JP6879582B2 (en)	2021-06-02
PH12016501519B1 (en)	2017-02-06
IL248090A0 (en)	2016-11-30
AU2015239736B2 (en)	2020-03-26
JP2021105062A (en)	2021-07-26
CA2938267A1 (en)	2015-10-08
AU2020203880A1 (en)	2020-07-02
PH12016501519A1 (en)	2017-02-06
CN113521017A (en)	2021-10-22
SI2926805T1 (en)	2016-09-30
US20180289714A1 (en)	2018-10-11
EP2926805B1 (en)	2016-05-18
US20220031703A9 (en)	2022-02-03
US11717522B2 (en)	2023-08-08
EP3125864A1 (en)	2017-02-08
US20170112836A1 (en)	2017-04-27
SA516371933B1 (en)	2019-04-14
KR20160138406A (en)	2016-12-05
EP2926805A1 (en)	2015-10-07
CY1117881T1 (en)	2018-03-07
RS54973B1 (en)	2016-11-30
ZA201605271B (en)	2017-08-30
US10016431B2 (en)	2018-07-10
MY180844A (en)	2020-12-10
BR112016020101A2 (en)	2017-07-15
AU2020203880B2 (en)	2022-03-31
CA2938267C (en)	2023-05-09
MX2016012784A (en)	2017-04-25
HUE030221T2 (en)	2017-04-28
IL248090B (en)	2019-10-31
JP7178731B2 (en)	2022-11-28
US9895372B2 (en)	2018-02-20

Publication	Publication Date	Title
IL282584A (en)	2021-06-30	Quinoline derivatives and pharmaceutical compositions containing them
IL258082B (en)	2022-10-01	Bezimidazole derivatives and pharmaceutical compositions containing them
IL251441A0 (en)	2017-05-29	Imidazo pyridine derivatives and pharmaceutical compositions containing them
HK1259145A1 (en)	2019-11-29	3-desoxy derivative and pharmaceutical compositions thereof
EP3139920A4 (en)	2017-11-01	Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
IL287947A (en)	2022-01-01	Reducing viscosity of pharmaceutical formulations
IL248090B (en)	2019-10-31	Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
IL280690A (en)	2021-03-25	Pharmaceutical compositions comprising dgla and use of same
IL249803B (en)	2020-03-31	Azepanyl derivatives and pharmaceutical compositions containing them
IL246630B (en)	2020-10-29	Pyrimidine pyrazolyl derivatives and pharmaceutical compositions containing them
HK1245086A1 (en)	2018-08-24	Pharmaceutical composition preparation and uses thereof
IL250306B (en)	2019-01-31	Heterocyclyl-carbonyl derivatives of indazole and pyrazolopyridine and pharmaceutical compositions comprising them
HK1245085A1 (en)	2018-08-24	Pharmaceutical composition preparation and uses thereof
HK1245113A1 (en)	2018-08-24	Pharmaceutical compositions and use thereof
SG10202008700VA (en)	2020-10-29	α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
HK1232211A1 (en)	2018-01-05	Dipicolylamine derivatives and their pharmaceutical uses
IL267279A (en)	2019-08-29	Pharmaceutical formulations of suvorexant
PT3503885T (en)	2022-04-19	Pharmaceutical composition and methods of uses
IL254711B (en)	2021-06-30	Diazepino-indole derivatives and pharmaceutical compositions comprising it
ZA201903341B (en)	2020-09-30	Pharmaceutical compositions and uses thereof
GB201604810D0 (en)	2016-05-04	Pharmaceutical compositions and uses
GB201514761D0 (en)	2015-09-30	Preparation and uses of pyrimidinone derivatives